| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2001 | CN1060336C Medicine for prevention and treatment of calcium deficiency and its prepn. |
| 01/10/2001 | CN1060334C Composite analgesic |
| 01/09/2001 | US6172261 Biosynthesis using chain extension |
| 01/09/2001 | US6172256 Chiral-β-amino acid compounds and derivatives thereof |
| 01/09/2001 | US6172250 Hydrolysis of an organosilicon compounds |
| 01/09/2001 | US6172239 Psychological, nervous system disorders |
| 01/09/2001 | US6172238 Process for manufacturing 1-[3-cyclopentyl-2(R)-[1(R)-hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperidine |
| 01/09/2001 | US6172237 Process for preparing eprosartan |
| 01/09/2001 | US6172229 1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands |
| 01/09/2001 | US6172227 Respiratory system disorders |
| 01/09/2001 | US6172209 Aminooxy-modified oligonucleotides and methods for making same |
| 01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
| 01/09/2001 | US6172193 Escape mutant of the surface antigen of hepatitis B virus |
| 01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
| 01/09/2001 | US6172119 Method of treating acute renal failure |
| 01/09/2001 | US6172118 Administering 3-phenylcyclobutan-1-one derivatives to treat asthma and respiratory system disorders; phosphodiesterase inhibitors |
| 01/09/2001 | US6172116 Use of aminoadamantane compounds as immunoregulators |
| 01/09/2001 | US6172115 Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid |
| 01/09/2001 | US6172114 Creatine supplement |
| 01/09/2001 | US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 01/09/2001 | US6172112 Anticarcinogenic and antitumor agents |
| 01/09/2001 | US6172111 Salt formation; antiobesity and strengthening agents |
| 01/09/2001 | US6172110 Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 01/09/2001 | US6172109 Side effect reduction; administering topically |
| 01/09/2001 | US6172108 Hydrazide compounds |
| 01/09/2001 | US6172107 Mycophenolate salt disintegrates selectively in intestines |
| 01/09/2001 | US6172106 Sesamol inhibition of Δ-5-desaturase activity and uses therefor |
| 01/09/2001 | US6172105 3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5 -carboxamide hydrogen tartrate synergistic mixture; anxiolytic agents, antidepressents; obsessive compulsive and psychological disorders |
| 01/09/2001 | US6172104 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 01/09/2001 | US6172103 Treating bone disorders, osteoporosis, and arthritis |
| 01/09/2001 | US6172102 Pyrrole derivatives and medicinal composition |
| 01/09/2001 | US6172100 Administering aminated 1-benzyl-2-phenylindole derivatives; benzylation |
| 01/09/2001 | US6172098 Methods and compositions for increasing the anaerobic working in tissues |
| 01/09/2001 | US6172097 Treating psychological, eating, sexual, and nervous system disorders; anxiolytic, adrenergic blocking, and antidepressant agents; serotonin reuptake inhibitors |
| 01/09/2001 | US6172096 Administering 4-pyrazolylbenzenesulfonamide derivatives to treat autoimmune diseases |
| 01/09/2001 | US6172095 Decongestants, analgesics, hypotensive agents; treating headaches, otitis media, sinusitus, gastrointestinal and respiratory system disorders; side effect reduction |
| 01/09/2001 | US6172091 Metabolic calcium imbalance and osteoporosis |
| 01/09/2001 | US6172090 Side effect reduction by administering an insulin sensitivity enhancer such as pioglitazone hydrochloride with a biguanide such as metformin |
| 01/09/2001 | US6172089 Pharmaceutical composition |
| 01/09/2001 | US6172088 Administering gonadotropin releasing hormone inhibitor |
| 01/09/2001 | US6172087 N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses |
| 01/09/2001 | US6172086 Methods and compositions for stimulating neurite growth |
| 01/09/2001 | US6172084 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/09/2001 | US6172080 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/09/2001 | US6172079 Benzodiazepine inverse agonists; alzheimer*s disease; anxiolytic agents, sedatives, muscle relaxants, antiepileptic agents |
| 01/09/2001 | US6172077 Tachykinin inhibitors; analgesics, antiinflammatory agents, antiemetics; neuralgia, headaches |
| 01/09/2001 | US6172074 Imidazopyridines and oxazolopyridines |
| 01/09/2001 | US6172072 Heterocyclically substituted benzamides and their use in fighting diseases |
| 01/09/2001 | US6172071 Anticholesterol agent |
| 01/09/2001 | US6172070 In polyoxyethylene glycol carrier |
| 01/09/2001 | US6172069 Controlling time of administering |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172067 Analgesics, antiinflammatory agents |
| 01/09/2001 | US6172062 Dihydrobenzodioxine carboxamide and ketone derivatives |
| 01/09/2001 | US6172061 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative |
| 01/09/2001 | US6172060 Therapy for sexual disorders |
| 01/09/2001 | US6172059 Controlling particle size |
| 01/09/2001 | US6172058 Nervous system disorders; psychological disorders |
| 01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
| 01/09/2001 | US6172056 Administering a estrogen compound |
| 01/09/2001 | US6172055 Therapy, prevention a neurodegenerative diseases |
| 01/09/2001 | US6172054 Angiostatic agent |
| 01/09/2001 | US6172053 Injection viral treatment |
| 01/09/2001 | US6172052 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 01/09/2001 | US6172050 Quaternary ammonium interior salt containing phosphate group |
| 01/09/2001 | US6172049 Supplying macromolecules to cells |
| 01/09/2001 | US6172048 Composition containing nucleic acids, preparation and uses |
| 01/09/2001 | US6172047 Therapy for nervous system tumors |
| 01/09/2001 | US6172042 Synthetic peptides that inhibit IL-6 activity |
| 01/09/2001 | US6172038 Antipathogenic peptides and compositions comprising them |
| 01/09/2001 | US6171860 Oligonucleotides which target untranslated regions and start codons to prevent transcription of a gene; for treatment of bone disorders, inflammation and cancer; antiinflammatory agents; anticarcinogenic agents; antitumor agents |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171838 ratB |
| 01/09/2001 | US6171835 ribH |
| 01/09/2001 | US6171830 Efficient purification of mycolic acids, salts or derivatives by dissolving mixture in bi-phasic solvent, subjecting to countercurrent distribution separation with sufficient cycles, then recovering |
| 01/09/2001 | US6171827 Procollagens |
| 01/09/2001 | US6171818 Amino acid sequence of polypeptide from aplysia punctata, a sea snail; for recombinant production of anticarcinogenic agents |
| 01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
| 01/09/2001 | US6171798 Diagnosing cancer or determining p53 status in a sample by comparing level of expression of specific genes to control; lower level indicates cancer |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/09/2001 | US6171786 Contacting cell with phosphoinositol-dependent phospholipase c inhibitor along with cytotoxic drug |
| 01/09/2001 | US6171778 Using solution containing arabinogalactan to remove impurities and protect viability |
| 01/09/2001 | US6171777 Decontaminating by contacting with compound, then recovering product; deactivates human immunodeficiency and hepatitis viruses; before transfusions or clinical tests |
| 01/09/2001 | US6171620 Method of enhancing the efficacy of anti-tumor agents |
| 01/09/2001 | US6171618 Combination dosage form comprising cetirizine and pseudoephedrine |
| 01/09/2001 | US6171617 Effervescent ibuprofen preparation and process for the production thereof |
| 01/09/2001 | US6171615 Semi-solid matrix of polyglycolized glycerides and nucleation enhancer |
| 01/09/2001 | US6171612 Gene therapy |
| 01/09/2001 | US6171609 Intravascular stent with cytoskeletal inhibitor; preventing stenosis or reducing restenosis |
| 01/09/2001 | US6171603 Treating skin, hair, cardiovascular, autoimmune and vision disorders; administering as anticarcinogenic, antidepressant,antiinflammatory, and antiacne agents |
| 01/09/2001 | US6171599 Process for producing efonidipine hydrochloride preparations |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/09/2001 | US6171597 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 01/09/2001 | US6171595 Skin external preparation |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/09/2001 | US6171583 Powdery iodine complexes |
| 01/09/2001 | US6171294 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 01/09/2001 | CA2117483C [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
| 01/09/2001 | CA2111854C Orally active antiviral compounds |